302 related articles for article (PubMed ID: 24854107)
1. Bioenergetic and proteolytic defects in fibroblasts from patients with sporadic Parkinson's disease.
Ambrosi G; Ghezzi C; Sepe S; Milanese C; Payan-Gomez C; Bombardieri CR; Armentero MT; Zangaglia R; Pacchetti C; Mastroberardino PG; Blandini F
Biochim Biophys Acta; 2014 Sep; 1842(9):1385-94. PubMed ID: 24854107
[TBL] [Abstract][Full Text] [Related]
2. Fibroblasts from skin biopsies as a tool for biomarker discovery in Parkinson׳s disease.
Mastroberardino PG; Ambrosi G; Blandini F; Milanese C; Sepe S
Free Radic Biol Med; 2014 Oct; 75 Suppl 1():S10. PubMed ID: 26461279
[TBL] [Abstract][Full Text] [Related]
3. The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease.
McNaught KS; Jnobaptiste R; Jackson T; Jengelley TA
Synapse; 2010 Mar; 64(3):241-50. PubMed ID: 19924695
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial remodeling in human skin fibroblasts from sporadic male Parkinson's disease patients uncovers metabolic and mitochondrial bioenergetic defects.
Deus CM; Pereira SP; Cunha-Oliveira T; Pereira FB; Raimundo N; Oliveira PJ
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165615. PubMed ID: 31759069
[TBL] [Abstract][Full Text] [Related]
5. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.
Sherer TB; Betarbet R; Stout AK; Lund S; Baptista M; Panov AV; Cookson MR; Greenamyre JT
J Neurosci; 2002 Aug; 22(16):7006-15. PubMed ID: 12177198
[TBL] [Abstract][Full Text] [Related]
6. Enhanced translocation of TRIM32 to mitochondria sensitizes dopaminergic neuronal cells to apoptosis during stress conditions in Parkinson's disease.
Goyani S; Shinde A; Shukla S; Saranga MV; Currim F; Mane M; Singh J; Roy M; Gohel D; Chandak N; Vasiyani H; Singh R
FEBS J; 2024 Jun; 291(12):2636-2655. PubMed ID: 38317520
[TBL] [Abstract][Full Text] [Related]
7. Peripheral mitochondrial function correlates with clinical severity in idiopathic Parkinson's disease.
Milanese C; Payán-Gómez C; Galvani M; Molano González N; Tresini M; Nait Abdellah S; van Roon-Mom WMC; Figini S; Marinus J; van Hilten JJ; Mastroberardino PG
Mov Disord; 2019 Aug; 34(8):1192-1202. PubMed ID: 31136028
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial and autophagic alterations in skin fibroblasts from Parkinson disease patients with Parkin mutations.
González-Casacuberta I; Juárez-Flores DL; Ezquerra M; Fucho R; Catalán-García M; Guitart-Mampel M; Tobías E; García-Ruiz C; Fernández-Checa JC; Tolosa E; Martí MJ; Grau JM; Fernández-Santiago R; Cardellach F; Morén C; Garrabou G
Aging (Albany NY); 2019 Jun; 11(11):3750-3767. PubMed ID: 31180333
[TBL] [Abstract][Full Text] [Related]
9. Geraniol Protects Against the Protein and Oxidative Stress Induced by Rotenone in an In Vitro Model of Parkinson's Disease.
Rekha KR; Inmozhi Sivakamasundari R
Neurochem Res; 2018 Oct; 43(10):1947-1962. PubMed ID: 30141137
[TBL] [Abstract][Full Text] [Related]
10. Effects of Commonly Used Pesticides in China on the Mitochondria and Ubiquitin-Proteasome System in Parkinson's Disease.
Chen T; Tan J; Wan Z; Zou Y; Afewerky HK; Zhang Z; Zhang T
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168786
[TBL] [Abstract][Full Text] [Related]
11. Effect of resveratrol on mitochondrial function: implications in parkin-associated familiar Parkinson's disease.
Ferretta A; Gaballo A; Tanzarella P; Piccoli C; Capitanio N; Nico B; Annese T; Di Paola M; Dell'aquila C; De Mari M; Ferranini E; Bonifati V; Pacelli C; Cocco T
Biochim Biophys Acta; 2014 Jul; 1842(7):902-15. PubMed ID: 24582596
[TBL] [Abstract][Full Text] [Related]
12. Rotenone Susceptibility Phenotype in Olfactory Derived Patient Cells as a Model of Idiopathic Parkinson's Disease.
Murtaza M; Shan J; Matigian N; Todorovic M; Cook AL; Ravishankar S; Dong LF; Neuzil J; Silburn P; Mackay-Sim A; Mellick GD; Wood SA
PLoS One; 2016; 11(4):e0154544. PubMed ID: 27123847
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70.
Mandel S; Grunblatt E; Riederer P; Amariglio N; Jacob-Hirsch J; Rechavi G; Youdim MB
Ann N Y Acad Sci; 2005 Aug; 1053():356-75. PubMed ID: 16179542
[TBL] [Abstract][Full Text] [Related]
14. Energy status, ubiquitin proteasomal function, and oxidative stress during chronic and acute complex I inhibition with rotenone in mesencephalic cultures.
Zeevalk GD; Bernard LP
Antioxid Redox Signal; 2005; 7(5-6):662-72. PubMed ID: 15890011
[TBL] [Abstract][Full Text] [Related]
15. Modulatory effects of sodium salicylate on the factors affecting protein aggregation during rotenone induced Parkinson's disease pathology.
Thakur P; Nehru B
Neurochem Int; 2014 Sep; 75():1-10. PubMed ID: 24852355
[TBL] [Abstract][Full Text] [Related]
16. Activation of adenosine triphosphate-sensitive potassium channels confers protection against rotenone-induced cell death: therapeutic implications for Parkinson's disease.
Tai KK; Truong DD
J Neurosci Res; 2002 Aug; 69(4):559-66. PubMed ID: 12210849
[TBL] [Abstract][Full Text] [Related]
17. Alterations in bioenergetic function induced by Parkinson's disease mimetic compounds: lack of correlation with superoxide generation.
Dranka BP; Zielonka J; Kanthasamy AG; Kalyanaraman B
J Neurochem; 2012 Sep; 122(5):941-51. PubMed ID: 22708893
[TBL] [Abstract][Full Text] [Related]
18. Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration.
Radad K; Rausch WD; Gille G
Neurochem Int; 2006 Sep; 49(4):379-86. PubMed ID: 16580092
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of rotenone-mediated cortical neuronal death: evidence for inhibition of ubiquitin-proteasome system and autophagy-lysosomal pathway, and dysfunction of mitochondrial and calcium signaling.
Yap YW; Chen MJ; Peng ZF; Manikandan J; Ng JM; Llanos RM; La Fontaine S; Beart PM; Cheung NS
Neurochem Int; 2013 Apr; 62(5):653-63. PubMed ID: 23186747
[TBL] [Abstract][Full Text] [Related]
20. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
Matsuda N; Tanaka K
J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
